DE69327247D1 - Physiologisch aktive substanz nk175203, verfahren zu deren herstellung und pharmazeutische verwendung - Google Patents

Physiologisch aktive substanz nk175203, verfahren zu deren herstellung und pharmazeutische verwendung

Info

Publication number
DE69327247D1
DE69327247D1 DE69327247T DE69327247T DE69327247D1 DE 69327247 D1 DE69327247 D1 DE 69327247D1 DE 69327247 T DE69327247 T DE 69327247T DE 69327247 T DE69327247 T DE 69327247T DE 69327247 D1 DE69327247 D1 DE 69327247D1
Authority
DE
Germany
Prior art keywords
production
active substance
physiologically active
pharmaceutical use
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69327247T
Other languages
English (en)
Other versions
DE69327247T2 (de
Inventor
Tomio Morino
Ayako Nakatani
Masayuki Kitagawa
Masaya Sato
Takashi Harada
Seiichi Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Publication of DE69327247D1 publication Critical patent/DE69327247D1/de
Application granted granted Critical
Publication of DE69327247T2 publication Critical patent/DE69327247T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69327247T 1992-09-09 1993-09-08 Physiologisch aktive substanz nk175203, verfahren zu deren herstellung und pharmazeutische verwendung Expired - Fee Related DE69327247T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26564692 1992-09-09
PCT/JP1993/001276 WO1994005679A1 (en) 1992-09-09 1993-09-08 Novel physiologically active substance nk175203, process for producing the same, and pharmaceutical use thereof

Publications (2)

Publication Number Publication Date
DE69327247D1 true DE69327247D1 (de) 2000-01-13
DE69327247T2 DE69327247T2 (de) 2000-05-18

Family

ID=17420032

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69327247T Expired - Fee Related DE69327247T2 (de) 1992-09-09 1993-09-08 Physiologisch aktive substanz nk175203, verfahren zu deren herstellung und pharmazeutische verwendung

Country Status (5)

Country Link
US (1) US5505944A (de)
EP (1) EP0659759B1 (de)
CA (1) CA2142453A1 (de)
DE (1) DE69327247T2 (de)
WO (1) WO1994005679A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU685275B2 (en) * 1994-05-23 1998-01-15 Nippon Kayaku Kabushiki Kaisha Neuron differentiation accelerator
US6114364A (en) * 1996-01-31 2000-09-05 Nippon Kayaku Co., Ltd. 2,3-disubstituted cyclopentanone derivatives, process for producing the same, and medicinal use thereof
WO1998048029A1 (fr) * 1997-04-24 1998-10-29 Nippon Kayaku Kabushiki Kaisha Procede de preparation de derives d'acide cyclopentanecarboxylique
US7659241B2 (en) 2002-07-31 2010-02-09 Seattle Genetics, Inc. Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623622A (en) * 1983-01-25 1986-11-18 Eleanor Roosevelt Institute For Cancer Research, Inc. T-cell growth factor and method of making same
US4840934A (en) * 1983-01-25 1989-06-20 Eleanor Roosevelt Institute For Cancer Research, Inc. Therapeutic method using T cell growth factor
US4822735A (en) * 1983-01-25 1989-04-18 Eleanor Roosevelt Institute For Cancer Research, Inc. T cell growth factor and method of making same
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
JPS61166710A (ja) * 1985-01-17 1986-07-28 Katsusato Fujiyoshi スベリ止め部材
EP0215126B1 (de) * 1985-02-08 1991-07-31 Chugai Seiyaku Kabushiki Kaisha Menschlicher granuloxcyt-kolonie-stimulierungsfaktor
JPS62236497A (ja) * 1985-09-17 1987-10-16 Chugai Pharmaceut Co Ltd 顆粒球コロニー刺激因子活性を有する糖蛋白質の製造方法
US5162317A (en) * 1988-05-12 1992-11-10 Esai Co., Ltd. Pyridinium salt and pharmacological composition containing the same
US5035878A (en) * 1988-09-12 1991-07-30 University Of Rochester Use of dithiocarbamates to counteract myelosuppression
JP2846331B2 (ja) * 1989-03-01 1999-01-13 電気化学工業株式会社 骨髄細胞分化増殖因子、その産生細胞及びその製法
US5223605A (en) * 1990-04-16 1993-06-29 Immunex Corporation Interleukin-4 binding protein-γ

Also Published As

Publication number Publication date
EP0659759B1 (de) 1999-12-08
WO1994005679A1 (en) 1994-03-17
US5505944A (en) 1996-04-09
EP0659759A1 (de) 1995-06-28
CA2142453A1 (en) 1994-03-17
DE69327247T2 (de) 2000-05-18
EP0659759A4 (de) 1995-07-05

Similar Documents

Publication Publication Date Title
ATE307576T1 (de) Fenofibrathaltige arzneizusammensetzung mit erhöhter bioverfügbarkeit und verfahren zu deren herstellung
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
AT400295B (de) Orale feste pharmazeutische dosierungsform mit programmierter wirkstofffreisetzung und verfahren zu ihrer herstellung
DE69723571D1 (de) Methyliden-malonat nanopartikel, verfahren zu deren herstellung, und diese enthaltende pharmazeutische praeparate
DE69131627D1 (de) Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung
ATE234291T1 (de) Metallproteinasehemmer, diesen enthaltende pharmazeutische zusammensetzung und dessen pharmazeutische verwendung und verfahren zu ihrer herstellung
DE50014587D1 (de) 16-halogen-epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung
DE58904479D1 (de) Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung.
ATA256092A (de) Aminosäurederivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE59709239D1 (de) 7alpha-(epsilon-aminoalkyl)-estratriene, verfahren zu deren herstellung, pharmazeutische präparate, die diese 7alpha-(epsilon-aminoalkyl)-estratriene enthalten sowie deren verwendung zur herstellung von arzneimitteln
ATA315488A (de) Neue adenosinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate
ATA176789A (de) Intravenös anwendbare pharmazeutische präparate und verfahren zu ihrer herstellung
ATA125988A (de) Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung
ATE166049T1 (de) Phthalimidoperoxihexansäure, verfahren zu deren herstellung und deren verwendung
ATE215951T1 (de) Tetracyclische campothecineanalogue, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen
ATE150033T1 (de) N,o-sulfatierte heparosane; verfahren zu deren herstellung und diese enthaltende arzneimittel
DE68901771D1 (de) Phospholipid enthaltende zusammensetzung, verfahren zu deren herstellung und verwendung als hilfsstoff fuer pharmazeutische substanzen.
DE69029186D1 (de) 3-Indolbrenztraubensäure, Verfahren zu deren Herstellung und deren therapeutische Verwendung
DE3863366D1 (de) Antibiotikum vermisporin, verfahren zu dessen herstellung und dasselbe als aktiver antibakterieller wirkstoff enthaltende pharmazeutische zusammensetzung.
DE59008160D1 (de) Feste pharmazeutische Präparate und Verfahren zu ihrer Herstellung.
DE68908374D1 (de) Propenonoximether, verfahren zu dessen herstellung sowie diese enthaltende arzneinmittel.
DE3680877D1 (de) Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69934781D1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
ATE94764T1 (de) Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee